FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Avon Weighing IPO and Bafna Pharmaceuticals IPO.
Avon Weighing IPO is a Mainline Fixed Price Issue IPO proposed to list at BSE while Bafna Pharmaceuticals IPO is a Mainline Fixed Price Issue proposed to list at BSE.
Avon Weighing IPO | Bafna Pharmaceuticals IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Fixed Price Issue |
Listing At | BSE | BSE |
Lead Managers | Keynote Financial Services Ltd | Keynote Financial Services Ltd Ashika Capital Ltd |
Registrar | Datamatics Financial Services Ltd | Cameo Corporate Services Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Avon Weighing IPO is up to ₹9.84 Cr whereas the issue size of the Bafna Pharmaceuticals IPO is up to ₹25.60 Cr. The final issue price of Avon Weighing IPO is ₹10.00 per share and of Bafna Pharmaceuticals IPO is ₹40.00 per share.
Avon Weighing IPO | Bafna Pharmaceuticals IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ₹10.00 per share | ₹40.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | ||
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 98,36,400 shares | 64,00,000 shares |
Issue Size Total (Amount) | up to ₹9.84 Cr | up to ₹25.60 Cr |
Avon Weighing IPO opens on Jun 09, 2008, while Bafna Pharmaceuticals IPO opens on May 27, 2008. The closing date of Avon Weighing IPO and Bafna Pharmaceuticals IPO is Jun 12, 2008, and May 30, 2008, respectively.
Avon Weighing IPO | Bafna Pharmaceuticals IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jun 09, 2008 | May 27, 2008 |
Issue Close | Jun 12, 2008 | May 30, 2008 |
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Avon Weighing IPO P/E ratio is , as compared to Bafna Pharmaceuticals IPO P/E ratio of .
Avon Weighing IPO | Bafna Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 71.07% | ||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 40.67% | 42.6% | ||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 31.93%% | 10.65%% |
In the Avon Weighing IPO retail investors (RII) are offered while in Bafna Pharmaceuticals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Avon Weighing IPO and in Bafna Pharmaceuticals IPO.
Avon Weighing IPO | Bafna Pharmaceuticals IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | ||
NII | ||
RII | ||
Employee | ||
Others | ||
Total |
Avon Weighing IPO subscribed in total, whereas Bafna Pharmaceuticals IPO subscribed .
Avon Weighing IPO | Bafna Pharmaceuticals IPO | |
---|---|---|
QIB (times) | ||
NII (times) | ||
Big NII (times) | ||
Small NII (times) | ||
RII (times) | ||
Employee (times) | ||
Other (times) | ||
Total (times) |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|